Details for New Drug Application (NDA): 203485
✉ Email this page to a colleague
The generic ingredient in PEMETREXED DISODIUM is pemetrexed disodium. There are twenty-nine drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the pemetrexed disodium profile page.
Summary for 203485
Tradename: | PEMETREXED DISODIUM |
Applicant: | Accord Hlthcare |
Ingredient: | pemetrexed disodium |
Patents: | 0 |
Pharmacology for NDA: 203485
Mechanism of Action | Folic Acid Metabolism Inhibitors |
Medical Subject Heading (MeSH) Categories for 203485
Suppliers and Packaging for NDA: 203485
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PEMETREXED DISODIUM | pemetrexed disodium | POWDER;INTRAVENOUS | 203485 | ANDA | Accord Healthcare Inc. | 16729-229 | 16729-229-03 | 1 VIAL in 1 CARTON (16729-229-03) / 4 mL in 1 VIAL |
PEMETREXED DISODIUM | pemetrexed disodium | POWDER;INTRAVENOUS | 203485 | ANDA | Accord Healthcare Inc. | 16729-230 | 16729-230-11 | 1 VIAL in 1 CARTON (16729-230-11) / 20 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 100MG BASE/VIAL | ||||
Approval Date: | May 25, 2022 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 500MG BASE/VIAL | ||||
Approval Date: | May 25, 2022 | TE: | AP | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 1GM BASE/VIAL | ||||
Approval Date: | May 25, 2022 | TE: | AP | RLD: | No |
Complete Access Available with Subscription